ONWARD's ARC-EX (Episode 126)
Guest: Dave Marver
In this episode, we have another insightful conversation with Dave Marver, CEO of ONWARD Medical. We discuss their FDA cleared transcutaneous stimulation device, the ARC-EX, as well as their other devices in the pipeline. Additionally, we talk about how the ARC-EX is being rolled out to physical therapy clinics and ONWARD Medical’s aspirations to obtain approval for home use of the device. We also discuss some of your questions at the end.
Listen on: Spotify | Apple Podcasts | Soundcloud
Bumper music: Dig a Hole by Freaque
Guest Bio
Dave Marver, MBA, is CEO of ONWARD Medical N.V. (Euronext: ONWD), which is developing breakthrough therapies for people with spinal cord injury. Dave spent almost 15 years with Medtronic in a variety of leadership positions around the world. Later, he served as CEO of Cardiac Science Corporation, a NASDAQ-listed company with 600 employees. He then founded and ran a high-profile sports technology start-up, raising $90M and developing three TIME Magazine Inventions of the Year. Dave has been an advisor to the World Bank’s International Finance Group and a member of the Health Industry Distributors Association Board of Directors and Duke University’s Health Sector Advisory Council. He has guest lectured at the graduate business schools for Duke University, University of Washington, and University of California at Los Angeles. Dave earned a BA from Duke University and an MBA from University of California at Los Angeles.
Connect with ONWARD Medical here:
- Website: onwd.com
- Facebook: @onwdempowered
- LinkedIn: @onwdempowered
- XTwitter: @onwdempowered
- Instagram: @onwdempowered
- Threads: @onwdempowered
- YouTube: @ONWARD_EMPOWERED
Related Resources
-
While the recent 60 Minutes feature story on ONWARD Medical focused solely on walking, their supplementary Overtime segment captured more of the holistic potential the device has for trying to restore various bodily functions after spinal cord injury.
-
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury
-
Feel free to submit any questions about the ARC-EX device to ONWARD via this webform.
This Episode Sponsored By:
